Mucin-binding protein shuttles enable delivery of brain-targeted therapeutics

CSF proteomic profiling with amyloid and tau pathology identifies distinctive sex-specific alteration of multiple proteins involved in Alzheimer’s disease

A Cerebrospinal Fluid Synaptic Protein Biomarker for Prediction of Resilience Versus Decline in Alzheimer’s Disease

Organ-specific aging signatures in the plasma proteome track health and disease

Plasma Biomarkers of Tau and Neurodegeneration During Major Cardiac and Noncardiac Surgery

Soluble TREM2 is Elevated in Parkinson’s Disease Subgroups with Increased CSF Tau